GU Cancers 2019 | Survival trends: urothelial vs. nonurothelial bladder cancer

Jeanny Aragon-Ching

Jeanny Aragon-Ching, MD, FACP, of the Inova Schar Cancer Institute, Fairfax, VA, discusses the comparative analyses of trends and survival in patients with urothelial versus nonurothelial bladder carcinoma: National Cancer Database (NCDB) analysis, presented at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video